MUC5B expression and location in surfactant protein C mutations in children

Pediatric Pulmonology

Volumn 50, Issue 12, 2015, Pages 1270-1276

  Liptzin, Deborah R ^a   Watson, Alan M ^b   Murphy, Elissa ^b   Kroehl, Miranda E ^c   Dishop, Megan K ^b   Galambos, Csaba ^b   Evans, Christopher M ^b   Schwarz, Marvin I ^b   Deterding, Robin R ^a   Schwartz, David A ^b  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Food Science and Human Nutrition   (United States)

Author keywords

bronchoalveolar lavage; interstitial lung disease; mucins; pediatrics; pulmonary fibrosis; rare diseases; single nucleotide polymorphism; surfactant

Indexed keywords

MUCIN 5B; SURFACTANT PROTEIN C; MUC5B PROTEIN, HUMAN;

ABCA3 GENE; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE; GENE LOCATION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LUNG FIBROSIS; LUNG LAVAGE; MALE; MOLECULAR PATHOLOGY; MUC5B GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SCHOOL CHILD; SURFACTANT PROTEIN C GENE; BRONCHOALVEOLAR LAVAGE FLUID; CASE CONTROL STUDY; CYTOLOGY; EPITHELIUM CELL; FIBROSING ALVEOLITIS; GENETICS; LUNG; LUNG ALVEOLUS; METABOLISM; MUTATION; NEWBORN; PILOT STUDY;

BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EPITHELIAL CELLS; FEMALE; GENOTYPE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LUNG; MALE; MUCIN-5B; MUTATION; PILOT PROJECTS; PROMOTER REGIONS, GENETIC; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C;

EID: 84955203612     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23180     Document Type: Conference Paper

References (24)

1. Thomas AQ, Lane K, Phillips J, 3rd, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, et al., Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002; 165: 1322-1328.
2. Abou Taam R, Jaubert F, Emond S, Le Bourgeois M, Epaud R, Karila C, Feldmann D, Scheinmann P, de Blic J,. Familial interstitial disease with I73T mutation: A mid- and long-term study. Pediatr Pulmonol 2009; 44: 167-175.
3. Thouvenin G, Abou Taam R, Flamein F, Guillot L, Le Bourgeois M, Reix P, Fayon M, Counil F, Depontbriand U, Feldmann D, et al., Characteristics of disorders associated with genetic mutations of surfactant protein C. Arch Dis Child 2010; 95: 449-454.
4. Hallik M, Annilo T, Ilmoja ML,. Different course of lung disease in two siblings with novel ABCA3 mutations. Eur J Pediatr 2013; 1-4.
5. Beers MF, Mulugeta S,. Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol 2005; 67: 663-696.
6. Thurm T, Kaltenborn E, Kern S, Griese M, Zarbock R,. SFTPC mutations cause SP-C degradation and aggregate formation without increasing ER stress. Eur J Clin Invest 2013; 43: 791-800.
7. Bridges JP, Wert SE, Nogee LM, Weaver TE,. Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. J Biol Chem 2003; 278: 52739-52746.
8. Maguire JA, Mulugeta S, Beers MF,. Endoplasmic reticulum stress induced by surfactant protein C BRICHOS mutants promotes proinflammatory signaling by epithelial cells. Am J Respir Cell Mol Biol 2011; 44: 404-414.
9. Wang WJ, Mulugeta S, Russo SJ, Beers MF,. Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative. J Cell Sci 2003; 116: 683-692.
10. Kropski JA, Lawson WE, Young LR, Blackwell TS,. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis. Dis Model Mech 2013; 6: 9-17.
11. Seibold MA, Smith RW, Urbanek C, Groshong SD, Cosgrove GP, Brown KK, Schwarz MI, Schwartz DA, Reynolds SD,. The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. PLoS ONE 2013; 8: e58658.
12. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, et al., A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011; 364: 1503-1512.
13. Sharma P, Dudus L, Nielsen PA, Clausen H, Yankaskas JR, Hollingsworth MA, Engelhardt JF,. MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol 1998; 19: 30-37.
14. Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch D, Groshong S, et al., Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 2013; 45: 613-620.
15. Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, Russell AM, Denton CP, Abraham DJ, Hansell DM, et al., Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax 2013; 68: 436-441.
16. Noth I, Zhang Y, Ma SF, Flores C, Barber M, Huang Y, Broderick SM, Wade MS, Hysi P, Scuirba J, et al., Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. Lancet Respir Med 2013; 1: 309-317.
17. Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, Kannengiesser C, Airo P, Matucci-Cerinic M, Wallaert B, Israel-Biet D, et al., The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. PLoS ONE 2013; 8: e70621.
18. Wei R, Li C, Zhang M, Jones-Hall YL, Myers JL, Noth I, Liu W,. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes. Transl Res 2014; 163: 494-502.
19. Zhang Y, Noth I, Garcia JG, Kaminski N,. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N Engl J Med 2011; 364: 1576-1577.
20. Groneberg DA, Eynott PR, Lim S, Oates T, Wu R, Carlstedt I, Roberts P, McCann B, Nicholson AG, Harrison BD, et al., Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology 2002; 40: 367-373.
21. Sagel SD, Sontag MK, Accurso FJ,. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis. Pediatr Pulmonol 2009; 44: 402-409.
22. Brown AM W, Thornton KK, Rousseau DJ, Evans K, Schwartz CM,. Serum Muc5b, A Potential Novel Diagnostic Biomarker for Idiopathic Pulmonary Fibrosis. In: American Thoracic Society San Diego, CA: American Journal of Respiratory and Critical Care Medicine; 2014.
23. Piccotti L, Dickey BF, Evans CM,. Assessment of intracellular mucin content in vivo. Methods Mol Biol 2012; 842: 279-295.
24. Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, Richards TJ, Silveira LJ, Lindell KO, Steele MP, Loyd JE, et al., Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 2013; 309: 2232-2239.